These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15150277)

  • 1. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis.
    Pakneshan P; Szyf M; Farias-Eisner R; Rabbani SA
    J Biol Chem; 2004 Jul; 279(30):31735-44. PubMed ID: 15150277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
    Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
    J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
    Pakneshan P; Xing RH; Rabbani SA
    FASEB J; 2003 Jun; 17(9):1081-8. PubMed ID: 12773490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
    Pakneshan P; Têtu B; Rabbani SA
    Clin Cancer Res; 2004 May; 10(9):3035-41. PubMed ID: 15131040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation.
    Xing RH; Rabbani SA
    Int J Cancer; 1999 May; 81(3):443-50. PubMed ID: 10209960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro.
    Zhao Y; Li JS; Guo MZ; Feng BS; Zhang JP
    Chin J Cancer; 2010 Aug; 29(8):752-60. PubMed ID: 20663323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications.
    Pakneshan P; Szyf M; Rabbani SA
    Curr Cancer Drug Targets; 2005 Nov; 5(7):471-88. PubMed ID: 16305345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
    Pulukuri SM; Estes N; Patel J; Rao JS
    Cancer Res; 2007 Feb; 67(3):930-9. PubMed ID: 17283123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
    Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
    Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.
    Hu Q; Lu YY; Noh H; Hong S; Dong Z; Ding HF; Su SB; Huang S
    Oncogene; 2013 Aug; 32(34):3933-43. PubMed ID: 22986534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
    Chik F; Machnes Z; Szyf M
    Carcinogenesis; 2014 Jan; 35(1):138-44. PubMed ID: 23985780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
    Huang HY; Jiang ZF; Li QX; Liu JY; Wang T; Zhang R; Zhao J; Xu YM; Bao W; Zhang Y; Jia LT; Yang AG
    Cancer Invest; 2010 Aug; 28(7):689-97. PubMed ID: 20636107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.
    Chik F; Szyf M
    Carcinogenesis; 2011 Feb; 32(2):224-32. PubMed ID: 20980350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
    Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
    Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.